Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03794167
What this trial is testing

BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Soonchunhyang University Hospital 75
Testing effectiveness (Phase 2)Study completedNCT05936567
What this trial is testing

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

Who this might be right for
UrticariaChronic Spontaneous UrticariaChronic Idiopathic Urticaria+3 more
Incyte Corporation 136
Testing effectiveness (Phase 2)Study completedNCT02135536
What this trial is testing

Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary Cirrhosis
NGM Biopharmaceuticals, Inc 36
Testing effectiveness (Phase 2)Study completedNCT00359944
What this trial is testing

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sumitomo Pharma America, Inc. 171
Testing effectiveness (Phase 2)Study completedNCT05808764
What this trial is testing

Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 11
Not applicableLooking for participantsNCT04219202
What this trial is testing

Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion

Who this might be right for
Sarcoma,Soft Tissue
University Hospital Heidelberg 64
Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing

Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA

Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT00001239
What this trial is testing

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03160430
What this trial is testing

A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis

Who this might be right for
Kidney Failure, Chronic
Resverlogix Corp 44
Testing effectiveness (Phase 2)WithdrawnNCT02649530
What this trial is testing

A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma, Head And Neck
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01725165
What this trial is testing

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 85
Testing effectiveness (Phase 2)Study completedNCT00791128
What this trial is testing

Study for Pre-Surgical Weight Loss in Type II Diabetes Patients

Who this might be right for
Type 2 DiabetesObesity
Morphic Medical Inc. 22
Testing effectiveness (Phase 2)Ended earlyNCT00549328
What this trial is testing

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 14
Early research (Phase 1)Study completedNCT01053767
What this trial is testing

Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

Who this might be right for
Group B Streptococcus (GBS) Disease
Novartis Vaccines 95
Testing effectiveness (Phase 2)Study completedNCT03085992
What this trial is testing

Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Azienda Ospedaliero, Universitaria Pisana 49
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Testing effectiveness (Phase 2)Looking for participantsNCT06363734
What this trial is testing

Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial

Who this might be right for
Non-small Cell Lung CancerEGFR Activating MutationCell Cycle Deregulation+1 more
Tianjin Medical University Cancer Institute and Hospital 32
Testing effectiveness (Phase 2)Study completedNCT01565109
What this trial is testing

NESC: Neoadjuvant Treatment of Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Recherche clinique 34
Testing effectiveness (Phase 2)UnknownNCT04524299
What this trial is testing

Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 160
Testing effectiveness (Phase 2)Study completedNCT03449199
What this trial is testing

Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria

Who this might be right for
Diabetic Kidney Disease
Teijin America, Inc. 130
Next Page